Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBIDECARENONE vs UMBRALISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

UBIDECARENONE vs UMBRALISIB: Safety Overview

Metric UBIDECARENONE UMBRALISIB
Total FAERS Reports 361 293
Deaths Reported 5 30
Death Rate 1.4% 10.2%
Hospitalizations 194 97
Average Patient Age 60.7 yrs 69.0 yrs
% Female Patients 82.6% 43.8%
FDA Approval Date N/A Feb 5, 2021
Manufacturer Energique, Inc. N/A
Route ORAL N/A
Marketing Status N/A Discontinued